Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 6/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA3 | P07451 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA6 | P23280 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylaminoethanol SCHEMBL21407663 | 0.83 | MAPT (0.55) | DNM1TSHRALDH1A1LMNAMAPT | |
| Hexane SCHEMBL16237730 | 0.81 | DNM1 (0.75) | DNM1TSHRALDH1A1CA12CA9 | |
| SCHEMBL9292699 | 0.80 | — | — | |
| SCHEMBL6369906 | 0.80 | TSHR (0.50) | DNM1TSHRALDH1A1TDP1LMNA | |
| SCHEMBL811 | 0.80 | — | — | |
| SCHEMBL546944 | 0.78 | — | — | |
| SCHEMBL1617151 | 0.77 | — | — | |
| Phosphine SCHEMBL20135762 | 0.77 | — | — | |
| Barium SCHEMBL11668415 | 0.77 | — | — | |
| SCHEMBL3441314 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015035012-A1 | FUSED THIOPHENE DITIN MONOMERS | CORNING INCORPORATED (US) | 2015-03-12 | — | — | WO | claimed |
| US-20150065722-A1 | FUSED THIOPHENE DITIN MONOMERS | CORNING INCORPORATED | 2015-03-05 | — | — | US | claimed |
| CN-105073114-B | Medicine for respiratory disorder | 第三共株式会社 | 2017-07-28 | — | — | CN | disclosed |
| WO-2015035012-A1 | FUSED THIOPHENE DITIN MONOMERS | CORNING INCORPORATED (US) | 2015-03-12 | — | — | WO | disclosed |
| US-20150065722-A1 | FUSED THIOPHENE DITIN MONOMERS | CORNING INCORPORATED | 2015-03-05 | — | — | US | disclosed |
| CN-102950025-B | Asymmetric hydrogenation catalyst of imine and its use | SINOCHEM CORP | 2014-09-10 | — | — | CN | disclosed |
| CN-102950025-A | Asymmetric hydrogenation catalyst of imine and its use | SINOCHEM CORP | 2013-03-06 | — | — | CN | disclosed |
| EP-1885728-A1 | CONVERSION OF AMORPHA-4,11- DIENE TO ARTEMISININ AND ARTEMISININ PRECURSORS | Amyris Biotechnologies, Inc. (US) | 2008-02-13 | — | — | EP | disclosed |
| US-7253232-B2 | Thermoplastic compositions with enhanced melt flow and compatibility | CIBA SPECIALTY CHEMICALS CORP. (US) | 2007-08-07 | — | — | US | disclosed |
| WO-2006128126-A1 | CONVERSION OF AMORPHA-4,11- DIENE TO ARTEMISININ AND ARTEMISININ PRECURSORS | AMYRIS BIOTECHNOLOGIES, INC. (US) | 2006-11-30 | — | — | WO | disclosed |
| US-20060270863-A1 | CONVERSION OF AMORPHA-4,11-DIENE TO ARTEMISININ AND ARTEMISININ PRECURSORS | AMYRIS BIOTECHNOLOGIES (US) | 2006-11-30 | — | — | US | disclosed |
| US-5681975-A | Single source metalloorgranic precursors to type 14-16 semiconductors | RUTGERS, THE STATE UNIVERSITY (US) | 1997-10-28 | — | — | US | disclosed |
| US-5283294-A | Crystalline polymer in rubber elastomer | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1994-02-01 | — | — | US | disclosed |
| US-5220042-A | Antiasthmatics, antiallergens, cardiovasculsr disorders | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-06-15 | — | — | US | disclosed |
| EP-0151995-B1 | NOVEL 1,4-BENZOQUINONE DERIVATIVES AND BENZENE DERIVATIVES, AND PROCESS FOR PREPARING THE SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-12-23 | — | — | EP | disclosed |
| EP-0282241-B1 | BETA-LACTAM COMPOUNDS AND PRODUCTION PROCESS THEREOF | Tamura, Yasumitsu (JP) | 1991-08-14 | — | — | EP | disclosed |
| EP-0336874-A1 | Inverse phase polymerization | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1989-10-11 | — | — | EP | disclosed |
| EP-0151995-A2 | Novel 1,4-benzoquinone derivatives and benzene derivatives, and process for preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1985-08-21 | — | — | EP | disclosed |
| US-4284581-A | LITHIUM 1,1'-BINAPHTHYL-2,2'-DIOXYALUMINUM HYDRIDE, REDUCING AGENTS | ONO PHARMACEUTICAL CO., LTD. (JP) | 1981-08-18 | — | — | US | disclosed |
| US-4029718-A | MOLDING MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060270863-A1 | CONVERSION OF AMORPHA-4,11-DIENE TO ARTEMISININ AND ARTEMISININ PRECURSORS | SQLE, CYP4A11, DHPS | DNM1 1359/4885TSHR 4597/4885ALDH1A1 217/4885 |
| US-20150065722-A1 | FUSED THIOPHENE DITIN MONOMERS | TTL, THEM6, ITK | DNM1 2909/4885TSHR 1590/4885ALDH1A1 2618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.